z-logo
open-access-imgOpen Access
Thrombolysis of a tricuspid prosthetic valve
Publication year - 2008
Publication title -
kardiovask med
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 2
eISSN - 1662-629X
pISSN - 1423-5528
DOI - 10.4414/cvm.2008.01335
Subject(s) - thrombolysis , medicine , tricuspid valve , cardiology , myocardial infarction
A 25-year-old Caucasian woman presented to our hospital in April 2005, complaining of exertional dyspnoea, palpitations and fatigue since three weeks. She underwent a mitral and tricuspid valve replacement with two mechanical prostheses in 1999 in Serbia for rheumatic mitral and tricuspid stenosis and was reoperated in 2003 for a subacute tricuspid prosthesis obstruction with implantation of a 31 mm bi-leaflet St. Jude valve. On physical examination she was an alert young woman without clinical signs of left or right heart failure. Cardiac auscultation revealed a large splitting of S1 associated to a /6 holosystolic murmur and /6 diastolic rumble on the left parasternal and apical regions. A transthoracic echocardiography (TTE) was performed and showed a normal left ventricular systolic function with a mild post-operative septal hypokinesia, a mildly dilated left atrium and a normally functioning mitral prosthetic valve. The right atrium was dilated and assumed a round shape with bulging of the interatrial septum to the left. There was a dilatation of the inferior vena cava and the sub-hepatic veins. The right ventricle was mildly dilated with a normal right ventricular systolic function. The posterior leaflet of the tricuspid prosthetis was jammed in a close position and there was an incomplete excursion of the anterior leaflet with a significant valvular leak. The mean transprosthetic gradient varied between 7 and 9 mm Hg (fig. 1–3). Adiagnosis of a subacute thrombosis of the tricuspid St. Jude valve was made and an intravenous thrombolysis was started. We administered a recombinant tissue plasminogen activator (rt-PA; Actilyse®, Boehringer Ingelheim, Germany) with a loading dose of 10 mg IV, followed by 90 mg IV for 90 min. Heparin 5000 U bolus IV was administered 2 hours after the loading dose, followed with 30000 U/ 24 h IV. One hour after the end of the thrombolysis, the diastolic rumble had disappeared. A transthoracic examination, 6 hours after the beginning of the fibrinolysis, showed a complete excursion of the two leaflets with a mean transprosthetic gradient of 2 mm Hg (fig. 1–3).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom